1. Home
  2. HSLV vs ARDX Comparison

HSLV vs ARDX Comparison

Compare HSLV & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HSLV

Highlander Silver Corp. Common Shares

N/A

Current Price

$4.94

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.21

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSLV
ARDX
Founded
N/A
2007
Country
Canada
United States
Employees
51
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
HSLV
ARDX
Price
$4.94
$5.21
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$15.14
AVG Volume (30 Days)
491.8K
4.7M
Earning Date
05-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
$37.60
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$4.08
52 Week High
$6.77
$8.40

Technical Indicators

Market Signals
Indicator
HSLV
ARDX
Relative Strength Index (RSI) 51.29 35.38
Support Level $4.10 $4.87
Resistance Level $5.30 $5.34
Average True Range (ATR) 0.27 0.32
MACD 0.06 -0.07
Stochastic Oscillator 72.13 16.61

Price Performance

Historical Comparison
HSLV
ARDX

About HSLV Highlander Silver Corp. Common Shares

Highlander Silver Corp. is a mineral exploration company engaged in the acquisition, exploration and evaluation of mineral properties located in Peru. It is focused on advancing the bonanza grade San Luis gold-silver project that is located in Central Peru. The company has determined that it has one operating segment, being the exploration of mineral properties.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: